Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Follicular

Explore clinical trials studying Lymphoma, Follicular. Study availability and eligibility vary by location and protocol.

1,362 public trials 202 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Follicular trial results

Completed

Fludarabine, Mitoxantrone and Rituximab in Relapsed or Primary Failing Advanced Follicular Non-Hodgkin's Lymphoma

NCT00169208

Conditions
Disease Attributes, Follicular Lymphoma, Hemic and Lymphatic Diseases, +12 more
Locations
  • Service de médecine D - Maladies du Sang CHU Angers Angers, France
  • Service d'Hématologie Hôpital Jean Minjoz Besançon, France
  • Hôpital Henri Mondor Créteil, France
  • Hôpital A. Michallon BP 217X Grenoble, France
View all 16 locations
View Trial Details
Completed

S0801 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma

NCT00770224

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Providence Cancer Center at Providence Hospital Mobile, Alabama, United States
  • Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States
  • Saint Anthony's Hospital at Saint Anthony's Health Center Alton, Illinois, United States
  • Cancer Care Center of Decatur Decatur, Illinois, United States
View all 114 locations
View Trial Details
Completed

Efficacy and Safety Study of Idelalisib in Participants With Indolent B-Cell Non-Hodgkin Lymphomas

NCT01282424

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +30 more
Locations
  • St. Jude Medical Center Fullerton, California, United States
  • Pacific Shores Medical Group Long Beach, California, United States
  • UCLA Los Angeles, California, United States
  • Central Coast Medical Oncology Santa Maria, California, United States
View all 41 locations
View Trial Details
Completed

A Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Lymphomas

NCT02401048

Conditions
Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +11 more
Locations
  • Site-0397 Birmingham, Alabama, United States
  • Site-0047 Duarte, California, United States
  • Site-0038 Stanford, California, United States
  • Site-0388 Miami, Florida, United States
View Trial Details
Completed

A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06)

NCT02213263

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Pacific Cancer Medical Center, Inc. Anaheim, California, United States
  • The Oncology Institute of Hope and Innovation Anaheim, California, United States
  • Compassionate Care Research Group, Inc., at Compassionate Cancer Care Medical Group, Inc. Corona, California, United States
  • The Oncology Institute of Hope and Innovation Downey, California, United States
View all 423 locations
View Trial Details
Completed

A Study Evaluating the Safety and Efficacy of Venetoclax (GDC-0199) Plus Bendamustine + Rituximab (BR) in Comparison With BR or Venetoclax Plus Rituximab in Participants With Relapsed and Refractory Follicular Non-Hodgkin's Lymphoma (fNHL)

NCT02187861

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Southern Cancer Center, PC Mobile, Alabama, United States
  • Arizona Cancer Center Tucson, Arizona, United States
  • UCLA School of Medicine; Hematology/Oncology Los Angeles, California, United States
  • Nothwest Georgia Oncology Centers P.C Austell, Georgia, United States
View all 71 locations
View Trial Details

Related conditions